Lonza will be exhibiting at SLAS2018, the annual show hosted by the Society for Laboratory Automation and Screening, in San Diego, CA (USA). At Booth 534 Lonza will showcase how its automated QC testing solutions and Nucleofector™ Devices can increase efficiency and throughput in the drug development process. In addition, Lonza is supporting a roundtable discussion on advanced in vitro cancer models for drug discovery and development.
Automated Solutions for QC Testing
At SLAS2018 Lonza’s QC testing experts will be on hand to demonstrate how the WinKQCL™ Endotoxin Detection and Analysis Software can interface with multiple robotic systems to provide a single database for data storage, management and reporting that complies with data-integrity regulations. At the Lonza booth, the team will also demonstrate how Lonza’s MODA™ Solution can automate environmental monitoring, product testing and trending to help laboratories to move away from labor-intensive and error-prone paper reporting. Scaling up Transfection ...